Citation

Collard DCM, Chinapaw MJ, Verhagen EA, Van Mechelen W. BMC Pediatr. 2010; 10(1): 86.

Copyright

(Copyright © 2010, Holtzbrinck Springer Nature Publishing Group - BMC)

DOI

10.1186/1471-2431-10-86

PMID

21092316

PMCID

PMC3004886

Abstract

BACKGROUND: In general, only information regarding the effectiveness of an intervention programme is ever published. However, in recent years evaluating the translatability and feasibility of an intervention programme has become more important. Therefore, this paper presents the results of the evaluation of the iPlay programme aimed at preventing physical activity related injuries in primary school children. METHODS: The iPlay programme targeted injuries gained through physical activity, and consisted of a teacher's manual, informative newsletters and posters, a website, and set exercises to be carried out during physical education (PE) classes. In order to evaluate the iPlay programme for translatability and feasibility, teachers, children and parents who participated in the iPlay programme filled out a questionaire The objective of this study is to describe the results of the process-evaluation of the iPlay programme based on the five dimensions of the RE-AIM framework. RESULTS: The results showed that the participation rate of the children was 100% (reach). Nine percent of the schools who were invited to take part were willing to participate in the study (adoption rate). Teachers stated that they implemented the different elements of the programme partly as intended (implementation). The percentage of children and parents who followed the programme was less than expected. In addition, 52% of the teachers indicated that the current iPlay programme could become standard practice in their teaching routine (maintenance). CONCLUSION: The iPlay programme is a first start in the prevention of physical activity related injuries in children, but further improvements need to be made to the programme on the basis of this process evaluation. Trial registration: ISRCTN78846684; www.controlled-trials.com.

Language: en